Disease Diagnostic Group Wins Investment at Launch NY
Dan Miner | Jan 13, 2017
Disease Diagnostics Group co-founders Alphonse Harris (left) and John Lewandowski.
CONTRIBUTED BY DDG
Two health sciences startup companies in Buffalo scored $50,000 investments from Launch NY on Thursday.
The investments – styled as debt that will eventually turn into equity – marked the conclusion of the Critical Path accelerator program, conducted with Launch NY, the University at Buffalo, Invest Buffalo Niagara and the Western New York Incubator Network. It’s part of the broader VilCap Communities initiative, sponsored by Steve Case‘s Rise of the Rest tour. Rise of the Rest named Buffalo a VilCap community after Case’s visit to the region in fall 2015.
Eight companies took part in the program, including Buffalo-based AccuTheranostics, Efferent Labs, Infonaut and Virtual Surgery Sim, Ithaca’s Ionica Sciences and Rochester’s Nidus Biosciences.
The winners, both from Buffalo, were:
Disease Diagnostic Group: The company operated throughout Buffalo during 2016 after winning $500,000 in a previous 43North competition and is now on the cusp of entering clinical trials – the scope of which will determine go-to-market strategies in the future, said Alphonse Harris, DDG chief operating officer. DDG has developed a low-cost diagnostic test for the developing world, with malaria as an early target…
